Case-Based Roundtable
General Dermatology
Eczema
Chronic Hand Eczema
Chronic Spontaneous Urticaria
Alopecia
Aesthetics
Vitiligo
COVID-19
Actinic Keratosis
Precision Medicine and Biologics
Rare Disease
Wound Care
Rosacea
Psoriasis
Psoriatic Arthritis
Atopic Dermatitis
Melasma
NP and PA
Skin Cancer
Hidradenitis Suppurativa
Drug Watch
Pigmentary Disorders
Acne
Pediatric Dermatology
Practice Management
Prurigo Nodularis
Buy-and-Bill

JAK Inhibitors in the Management of Atopic Dermatitis : Episode 4

Video

December 13, 2022

Importance of Clinical Trial Data, Disease Control, and QoL in Atopic Dermatitis Management

Author(s):

Raj Chovatiya, MD, PhD, MSCI,Neal Bhatia, MD

Raj Chovatiya, M.D., Ph.D. and Neal Bhatia, MD comment on the importance of assessing a treatment’s available clinical trial data, ability to control disease severity, and QoL impacts when assessing atopic dermatitis treatment options.

EP: 1.Expert Perspectives on the Rapid Expansion of Atopic Dermatitis Treatments

EP: 2.Atopic Dermatitis Treatment Biological Targets

EP: 3.Use of JAK Inhibitors in Clinical Practice

Now Viewing

EP: 4.Importance of Clinical Trial Data, Disease Control, and QoL in Atopic Dermatitis Management

EP: 5.Final Thoughts for Atopic Dermatitis Treatment

EP: 6.Frontline Forum Part 1: A Discussion of the Current Treatment Landscape for Atopic Dermatitis

EP: 7.Frontline Forum Part 2: A Discussion of the Current Treatment Landscape for Atopic Dermatitis

EP: 8.Frontline Forum Part 3: A Discussion of the Current Treatment Landscape for Atopic Dermatitis

EP: 9.Frontline Forum Part 4: A Discussion of the Current Treatment Landscape for Atopic Dermatitis

EP: 10.Frontline Forum Part 5: A Discussion of the Current Treatment Landscape for Atopic Dermatitis

EP: 11.Expert Perspective on the Care of Patients with Atopic Dermatitis

EP: 12.Role of Disease Severity in Topical vs Systemic AD Treatment

EP: 13.Efficacy and Safety of JAK inhibitors for AD

EP: 14.Optimizing Patient Outcomes with JAK Inhibitors

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Subscribe Now!